Sirona Biochem Past Earnings Performance

Past criteria checks 0/6

Sirona Biochem has been growing earnings at an average annual rate of 15.7%, while the Biotechs industry saw earnings growing at 13.4% annually. Revenues have been growing at an average rate of 6.6% per year.

Key information

15.7%

Earnings growth rate

20.5%

EPS growth rate

Biotechs Industry Growth-14.6%
Revenue growth rate6.6%
Return on equityn/a
Net Margin16,294.9%
Last Earnings Update31 Jul 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Sirona Biochem makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:ZSB Revenue, expenses and earnings (CAD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Jul 240-311
30 Apr 240-211
31 Jan 240-311
31 Oct 230-311
31 Jul 230-211
30 Apr 231-221
31 Jan 231-221
31 Oct 221-431
31 Jul 221-331
30 Apr 220-431
31 Jan 220-431
31 Oct 210-211
31 Jul 210-211
30 Apr 210-311
31 Jan 210-311
31 Oct 200-431
31 Jul 200-541
30 Apr 200-541
31 Jan 200-651
31 Oct 190-531
31 Jul 190-421
30 Apr 191-221
31 Jan 191-211
31 Oct 181-111
31 Jul 181-311
30 Apr 181-411
31 Jan 181-421
31 Oct 170-421
31 Jul 170-321
30 Apr 170-321
31 Jan 170-321
31 Oct 160-321
31 Jul 160-321
30 Apr 160-321
31 Jan 160-421
31 Oct 150-421
31 Jul 150-321
30 Apr 150-321
31 Jan 150-331
31 Oct 140-430
31 Jul 140-431
30 Apr 140-431
31 Jan 140-321

Quality Earnings: ZSB is currently unprofitable.

Growing Profit Margin: ZSB is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: ZSB is unprofitable, but has reduced losses over the past 5 years at a rate of 15.7% per year.

Accelerating Growth: Unable to compare ZSB's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: ZSB is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (-18.6%).


Return on Equity

High ROE: ZSB's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Return on Assets


Return on Capital Employed


Discover strong past performing companies